Clinical Trial Update: Pressure Targeting During High Flow Therapy in Premature Infants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Texas at Austin evaluating pressure targeting during high-flow therapy in premature infants with neonata…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome

Snippet

Sponsor: University of Texas at Austin | Conditions: Preterm Infants, Respiratory Distress Syndrome (Neonatal) | Phase 2 | Status: NOT_YET_RECRUITING